Procter & Gamble (PG) Financials

$152.62 +0.41 (+0.27%)

Closing price 10/24/2025 03:59 PM Eastern

Extended Trading

$152.63 +0.01 (+0.00%)

As of 10/24/2025 07:59 PM Eastern

Annual Income Statements for Procter & Gamble

This table shows Procter & Gamble's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	6/30/2015	6/30/2016	6/30/2017	6/30/2018	6/30/2019	6/30/2020	6/30/2021	6/30/2022	6/30/2023	6/30/2024	6/30/2025
Net Income / (Loss) Attributable to Common Shareholders	7,036	10,508	15,326	9,750	3,897	13,027	14,306	14,742	14,653	14,879	15,974
Consolidated Net Income / (Loss)	7,144	10,604	15,411	9,861	3,966	13,103	14,352	14,793	14,738	14,974	16,065
Net Income / (Loss) Continuing Operations	8,287	10,027	10,194	9,861	3,966	13,103	14,352	14,793	14,738	14,974	16,065
Total Pre-Tax Income	11,012	13,369	13,257	13,326	6,069	15,834	17,615	17,995	18,353	18,761	20,167
Total Operating Income	11,049	13,441	13,766	13,363	5,487	15,706	17,986	17,813	18,134	18,545	20,451
Total Gross Profit	33,693	32,390	32,420	32,400	32,916	35,700	39,010	38,030	39,246	43,191	43,120
Total Revenue	70,749	65,299	65,058	66,832	67,684	70,950	76,118	80,187	82,006	84,039	84,284
Operating Revenue	70,749	65,299	65,058	66,832	67,684	70,950	76,118	80,187	82,006	84,039	84,284
Total Cost of Revenue	37,056	32,909	32,638	34,432	34,768	35,250	37,108	42,157	42,760	40,848	41,164
Operating Cost of Revenue	37,056	32,909	32,638	34,432	34,768	35,250	37,108	42,157	42,760	40,848	41,164
Total Operating Expenses	22,644	18,949	18,654	19,037	27,429	19,994	21,024	20,217	21,112	24,646	22,669
Selling, General & Admin Expense	20,616	18,949	18,654	19,037	19,084	19,994	21,024	20,217	21,112	23,305	22,669
Impairment Charge	-	-	0.00	0.00	8,345	-	-	0.00	0.00	1,341	0.00
Total Other Income / (Expense), net	-37	-72	-509	-37	582	128	-371	182	219	216	-284
Interest Expense	626	579	465	506	509	465	502	439	756	925	907
Interest & Investment Income	149	182	171	247	220	155	45	51	307	473	469
Other Income / (Expense), net	440	325	-215	222	871	438	86	570	668	668	154
Income Tax Expense	2,725	3,342	3,063	3,465	2,103	2,731	3,263	3,202	3,615	3,787	4,102
Net Income / (Loss) Attributable to Noncontrolling Interest	108	96	85	111	69	76	46	51	85	95	91
Basic Earnings per Share	$2.50	$3.80	$5.80	$3.75	$1.45	$5.13	$5.69	$6.00	$6.07	$6.18	$6.67
Weighted Average Basic Shares Outstanding	-16.75B	50.04B	2.60B	2.49B	2.50B	4.97B	4.85B	4.78B	4.71B	2.35B	2.34B
Diluted Earnings per Share	$2.44	$3.69	$5.59	$3.67	$1.43	$4.96	$5.50	$5.81	$5.90	$6.02	$6.51
Weighted Average Diluted Shares Outstanding	-16.75B	50.04B	2.60B	2.49B	2.50B	4.97B	4.85B	4.78B	4.71B	2.35B	2.34B
Weighted Average Basic & Diluted Shares Outstanding	-16.75B	50.04B	2.60B	2.49B	2.50B	4.97B	4.85B	4.78B	4.71B	2.35B	2.34B
Cash Dividends to Common per Share	$2.59	$2.66	$3.00	-	$2.90	$3.03	$3.24	$3.52	$3.68	$3.83	$4.08

This table shows Procter & Gamble's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025
Net Income / (Loss) Attributable to Common Shareholders	3,397	3,384	4,521	3,468	3,754	3,136	3,959	4,630	3,769	3,616	4,750
Consolidated Net Income / (Loss)	3,424	3,392	4,556	3,493	3,781	3,144	3,987	4,659	3,793	3,626	4,781
Net Income / (Loss) Continuing Operations	3,424	3,392	4,556	3,493	3,780	3,145	3,988	4,658	3,793	3,626	4,781
Total Pre-Tax Income	4,288	4,233	5,802	4,496	4,592	3,871	5,140	5,845	4,661	4,521	6,034
Total Operating Income	4,248	4,162	5,767	4,433	4,460	3,885	5,797	5,741	4,558	4,355	5,856
Total Gross Profit	9,664	9,940	11,370	11,297	10,340	10,184	11,316	11,464	10,082	10,258	11,499
Total Revenue	20,068	20,553	21,871	21,441	20,195	20,532	21,737	21,882	19,776	20,889	22,386
Operating Revenue	20,068	20,553	21,871	21,441	20,195	20,532	21,737	21,882	19,776	20,889	22,386
Total Cost of Revenue	10,404	10,613	10,501	10,144	9,855	10,348	10,421	10,418	9,694	10,631	10,887
Operating Cost of Revenue	10,404	10,613	10,501	10,144	9,855	10,348	10,421	10,418	9,694	10,631	10,887
Total Operating Expenses	5,416	5,778	5,604	6,863	5,880	6,299	5,519	5,723	5,524	5,903	5,643
Selling, General & Admin Expense	5,416	5,778	5,604	5,522	5,880	6,299	5,519	5,723	5,524	5,903	5,643
Total Other Income / (Expense), net	40	71	35	62	131	-12	-657	103	104	166	179
Interest Expense	222	240	225	248	233	219	238	240	217	212	197
Interest & Investment Income	83	116	128	133	104	108	135	119	111	104	108
Other Income / (Expense), net	179	195	132	177	260	99	-554	224	210	274	268
Income Tax Expense	864	841	1,246	1,003	812	726	1,152	1,187	868	895	1,253
Net Income / (Loss) Attributable to Noncontrolling Interest	27	8.00	35	25	27	8.00	28	29	23	11	31
Basic Earnings per Share	$1.41	$1.41	$1.89	$1.44	$1.56	$1.29	$1.65	$1.94	$1.58	$1.50	$2.00
Weighted Average Basic Shares Outstanding	2.36B	4.71B	2.36B	2.35B	2.36B	2.35B	2.36B	2.34B	2.34B	2.34B	2.34B
Diluted Earnings per Share	$1.37	$1.37	$1.83	$1.40	$1.52	$1.27	$1.61	$1.88	$1.54	$1.48	$1.95
Weighted Average Diluted Shares Outstanding	2.36B	4.71B	2.36B	2.35B	2.36B	2.35B	2.36B	2.34B	2.34B	2.34B	2.34B
Weighted Average Basic & Diluted Shares Outstanding	2.36B	4.71B	2.36B	2.35B	2.36B	2.35B	2.36B	2.34B	2.34B	2.34B	2.34B

This table details how cash moves in and out of Procter & Gamble's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	6/30/2015	6/30/2016	6/30/2017	6/30/2018	6/30/2019	6/30/2020	6/30/2021	6/30/2022	6/30/2023	6/30/2024	6/30/2025
Net Change in Cash & Equivalents	-1,712	266	-2,529	-3,000	1,758	11,942	-5,893	-3,074	1,032	1,235	75
Net Cash From Operating Activities	14,608	15,435	12,753	14,867	15,242	17,403	18,371	16,723	16,848	19,846	17,817
Net Cash From Continuing Operating Activities	14,608	15,435	12,753	14,867	15,242	17,403	18,371	16,723	16,848	19,847	17,818
Net Income / (Loss) Continuing Operations	7,144	10,604	15,411	9,861	3,966	13,103	14,352	14,793	14,738	14,974	16,065
Consolidated Net Income / (Loss)	7,144	10,604	15,411	9,861	3,966	13,103	14,352	14,793	14,738	14,974	16,065
Depreciation Expense	3,134	3,078	2,820	2,834	2,824	3,013	2,735	2,807	2,714	2,896	2,847
Non-Cash Adjustments To Reconcile Net Income	4,519	928	-4,434	-1,279	8,495	-31	778	41	722	1,935	-273
Changes in Operating Assets and Liabilities, net	-189	825	-1,044	3,451	-43	1,318	506	-918	-1,326	42	-821
Net Cash From Investing Activities	-2,890	-5,575	-6,685	-3,511	-3,490	3,045	-2,834	-4,424	-3,500	-3,504	-3,818
Net Cash From Continuing Investing Activities	-2,890	-5,575	-6,210	-3,511	-3,490	3,045	-2,834	-4,424	-3,500	-3,504	-3,818
Purchase of Property, Plant & Equipment	-3,736	-3,314	-3,384	-3,717	-3,347	-3,073	-2,787	-3,156	-3,062	-3,322	-3,773
Acquisitions	-137	-186	-16	-109	-3,945	-58	-34	-1,381	-765	-21	-11
Sale of Property, Plant & Equipment	4,498	432	571	269	394	30	42	110	46	346	107
Sale and/or Maturity of Investments	1,040	1,447	1,488	3,955	3,628	6,146	-55	3.00	281	-507	-141
Net Cash From Financing Activities	-13,019	-9,213	-8,568	-14,375	-9,994	-8,367	-21,531	-14,876	-12,146	-14,855	-14,036
Net Cash From Continuing Financing Activities	-13,019	-9,213	-8,568	-14,375	-9,994	-8,367	-21,531	-14,876	-12,146	-14,855	-14,035
Repayment of Debt	-6,092	-2,631	-4,931	-6,310	-3,184	-14,473	-15,995	-12,904	-18,228	-9,167	-9,627
Repurchase of Common Equity	-4,604	-4,004	-5,204	-7,004	-5,003	-7,405	-11,009	-10,003	-7,353	-5,006	-6,500
Payment of Dividends	-7,287	-7,436	-7,236	-7,310	-7,498	-7,789	-8,263	-8,770	-8,999	-9,312	-9,872
Issuance of Debt	2,138	3,916	6,330	5,072	2,367	19,322	12,092	14,796	21,165	6,725	10,257
Other Financing Activities, net	2,826	942	2,473	1,177	3,324	1,978	1,644	2,005	1,269	1,905	1,707
Other Net Changes in Cash	-	-	-	19	-	-139	101	-497	-170	-251	112
Cash Interest Paid	678	569	518	529	497	434	531	451	721	878	896
Cash Income Taxes Paid	4,558	3,730	3,714	2,830	3,064	3,550	3,822	3,818	4,278	4,363	4,554

This table details how cash moves in and out of Procter & Gamble's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025
Net Change in Cash & Equivalents	742	650	1,487	-1,843	-1,111	2,653	2,675	-1,927	-1,113	440	1,615
Net Cash From Operating Activities	3,863	5,341	4,904	5,100	4,088	5,754	4,302	4,825	3,705	4,985	5,408
Net Cash From Continuing Operating Activities	3,863	5,341	4,904	5,100	4,089	5,754	4,302	4,825	3,704	4,987	5,409
Net Income / (Loss) Continuing Operations	3,424	3,392	4,556	3,493	3,781	3,144	3,987	4,659	3,793	3,626	4,781
Consolidated Net Income / (Loss)	3,424	3,392	4,556	3,493	3,781	3,144	3,987	4,659	3,793	3,626	4,781
Depreciation Expense	692	706	702	721	712	761	728	706	690	723	761
Non-Cash Adjustments To Reconcile Net Income	193	10	224	1,735	-442	1,140	-365	80	201	-1,637	-226
Changes in Operating Assets and Liabilities, net	-446	1,233	-578	-849	38	709	-48	-620	-980	2,275	93
Net Cash From Investing Activities	-1,380	-798	-1,222	-1,002	-762	-518	-1,108	-921	-726	-1,063	-1,535
Net Cash From Continuing Investing Activities	-1,380	-798	-1,222	-1,001	-763	-518	-1,108	-922	-727	-1,061	-1,535
Purchase of Property, Plant & Equipment	-730	-734	-925	-817	-797	-783	-993	-925	-859	-996	-1,200
Acquisitions	-	-	0.00	-	-	-	-6.00	-	-5.00	-	-5.00
Sale of Property, Plant & Equipment	1.00	37	3.00	5.00	69	269	45	2.00	17	43	8.00
Sale and/or Maturity of Investments	-13	-50	-300	-189	-	-4.00	-154	1.00	120	-108	-338
Net Cash From Financing Activities	-1,753	-3,893	-2,038	-6,049	-4,269	-2,499	-634	-5,571	-4,215	-3,616	-2,239
Net Cash From Continuing Financing Activities	-1,753	-3,893	-2,037	-6,052	-4,267	-2,499	-634	-5,570	-4,216	-3,615	-2,237
Repayment of Debt	-4,502	-6,830	-738	-3,719	670	-1,640	-1,085	-3,669	-1,048	-3,825	305
Repurchase of Common Equity	-1,351	-	-1,500	-1,003	-987	-1,516	-1,939	-2,510	-1,351	-700	-1,250
Payment of Dividends	-2,224	-2,289	-2,290	-2,288	-2,285	-2,449	-2,445	-2,441	-2,433	-2,553	-2,549
Issuance of Debt	5,900	4,818	2,179	873	-2,233	2,166	4,090	2,810	-	3,357	1,123
Other Financing Activities, net	424	408	312	85	568	940	745	240	616	106	134
Effect of Exchange Rate Changes	-	-	-	-	-	-	116	-	122	-	-20

This table presents Procter & Gamble's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	6/30/2015	6/30/2016	6/30/2017	6/30/2018	6/30/2019	6/30/2020	6/30/2021	6/30/2022	6/30/2023	6/30/2024	6/30/2025
Total Assets	129,495	127,136	120,406	118,310	115,095	120,700	119,307	117,208	120,829	122,370	125,231
Total Current Assets	29,646	33,782	26,494	23,320	22,473	27,987	23,091	21,653	22,648	24,709	25,392
Cash & Equivalents	6,836	7,102	5,569	2,569	4,239	-	10,288	-	8,246	9,482	9,556
Accounts Receivable	4,568	4,373	4,594	4,686	4,951	4,178	4,725	5,143	5,471	6,118	6,185
Inventories, net	4,979	4,716	4,624	4,738	5,017	5,498	5,983	6,924	7,073	7,016	7,550
Prepaid Expenses	2,708	2,653	2,139	2,046	2,218	2,130	2,095	2,372	1,858	2,095	2,100
Plant, Property, & Equipment, net	19,655	19,385	19,893	20,600	21,271	20,692	21,686	21,195	21,909	22,152	23,897
Total Noncurrent Assets	80,194	73,969	74,019	74,390	71,351	72,021	74,530	74,360	76,272	75,508	75,941
Goodwill	44,622	44,350	44,699	45,175	40,273	39,901	40,924	39,700	40,659	40,303	41,650
Intangible Assets	25,010	24,527	24,187	23,902	24,215	23,792	23,642	23,679	23,783	22,047	21,910
Other Noncurrent Operating Assets	5,358	5,092	5,133	5,313	6,863	8,328	9,964	10,981	11,830	13,158	12,381
Total Liabilities & Shareholders' Equity	129,495	127,136	120,406	118,310	115,095	120,700	119,307	117,208	120,829	122,370	125,231
Total Liabilities	66,445	69,153	64,628	65,427	67,516	73,822	72,653	70,354	73,764	71,811	72,946
Total Current Liabilities	29,790	30,770	30,210	28,237	30,011	32,976	33,132	33,081	35,756	33,627	36,058
Short-Term Debt	12,018	11,653	13,554	10,423	9,697	11,183	8,889	8,645	10,229	7,191	9,513
Accounts Payable	8,138	9,325	9,632	10,344	11,260	12,071	13,720	14,882	14,598	15,364	15,227
Accrued Expenses	8,091	7,449	7,024	7,470	9,054	9,722	10,523	9,554	10,929	11,073	11,318
Total Noncurrent Liabilities	36,655	38,383	34,418	37,190	37,505	40,846	39,521	37,273	38,008	38,183	36,889
Long-Term Debt	18,327	18,945	18,038	20,863	20,395	23,537	23,099	22,848	24,378	25,269	24,995
Noncurrent Deferred & Payable Income Tax Liabilities	9,179	9,113	8,126	6,163	6,899	6,199	6,153	6,809	6,478	6,516	5,774
Other Noncurrent Operating Liabilities	8,432	10,325	8,254	10,164	10,211	11,110	10,269	7,616	7,152	6,398	6,120
Total Equity & Noncontrolling Interests	63,050	57,983	55,778	52,883	47,579	46,878	46,654	46,854	47,065	50,559	52,284
Total Preferred & Common Equity	62,419	57,341	55,184	52,293	47,194	46,424	46,308	46,589	46,777	50,286	52,012
Preferred Stock	1,077	1,038	1,006	967	928	800	800	843	819	798	777
Total Common Equity	61,342	56,303	54,178	51,326	46,266	45,624	45,508	45,746	45,958	49,488	51,235
Common Stock	67,861	67,723	67,650	67,855	67,836	68,203	68,857	69,804	70,565	71,693	72,779
Retained Earnings	84,807	87,953	96,124	98,641	94,918	100,239	106,374	112,429	118,170	123,811	129,973
Treasury Stock	-77,226	-82,176	-93,715	-99,217	-100,406	-105,573	-114,973	-123,382	-129,736	-133,379	-138,702
Accumulated Other Comprehensive Income / (Loss)	-12,780	-15,907	-14,632	-14,749	-14,936	-16,165	-13,744	-12,189	-12,220	-11,900	-12,143
Other Equity Adjustments	-1,320	-1,290	-1,249	-1,204	-1,146	-1,080	-1,006	-916	-821	-737	-672
Noncontrolling Interest	631	642	594	590	385	357	276	265	288	272	272

This table presents Procter & Gamble's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026
Period end date	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	9/30/2025
Total Assets	117,715	119,851	120,829	122,531	120,709	119,598	122,370	126,482	122,639	122,984	127,599
Total Current Assets	21,866	22,305	22,648	24,940	23,111	22,458	24,709	27,449	25,642	24,435	27,118
Cash & Equivalents	-	-	8,246	-	-	6,828	9,482	12,156	10,230	9,116	11,171
Accounts Receivable	5,767	5,471	5,471	6,215	6,334	6,124	6,118	6,314	6,234	6,139	6,487
Inventories, net	7,541	7,483	7,073	7,117	7,152	7,078	7,016	7,287	7,020	7,400	7,848
Prepaid Expenses	1,704	1,755	1,858	1,875	1,736	2,428	2,095	1,692	2,158	1,780	1,612
Plant, Property, & Equipment, net	21,167	21,564	21,909	21,636	22,132	22,027	22,152	22,506	22,074	22,728	24,119
Total Noncurrent Assets	74,682	75,982	76,272	75,955	75,466	75,113	75,508	76,526	74,923	75,820	76,362
Goodwill	39,951	40,718	40,659	40,239	40,916	40,567	40,303	40,970	39,898	40,476	41,643
Intangible Assets	23,594	23,832	23,783	23,637	22,302	22,193	22,047	22,053	21,833	21,836	21,818
Other Noncurrent Operating Assets	11,137	11,432	11,830	12,079	12,248	12,353	13,158	13,503	13,192	13,508	12,901
Total Liabilities & Shareholders' Equity	117,715	119,851	120,829	122,531	120,709	119,598	122,370	126,482	122,639	122,984	127,599
Total Liabilities	72,990	74,430	73,764	74,517	71,880	69,264	71,811	74,341	71,195	70,439	74,048
Total Current Liabilities	38,746	38,030	35,756	37,158	35,950	32,340	33,627	36,420	33,797	34,248	37,995
Short-Term Debt	14,300	13,717	10,229	11,811	10,616	7,729	7,191	10,409	9,424	9,889	11,631
Accounts Payable	14,153	13,790	14,598	14,435	14,234	13,691	15,364	15,350	14,495	14,512	15,609
Accrued Expenses	10,293	10,523	10,929	10,912	11,100	10,921	11,073	10,661	9,879	9,847	10,756
Total Noncurrent Liabilities	34,244	36,400	38,008	37,360	35,929	36,923	38,183	37,921	37,399	36,191	36,052
Long-Term Debt	20,582	22,874	24,378	24,069	23,096	24,253	25,269	25,744	25,263	24,252	24,315
Noncurrent Deferred & Payable Income Tax Liabilities	6,462	6,422	6,478	6,814	6,219	6,284	6,516	6,420	6,725	6,481	5,893
Other Noncurrent Operating Liabilities	7,200	7,104	7,152	6,477	6,614	6,386	6,398	5,757	5,411	5,458	5,844
Total Equity & Noncontrolling Interests	44,725	45,421	47,065	48,014	48,829	50,333	50,559	52,141	51,443	52,545	53,551
Total Preferred & Common Equity	44,455	45,140	46,777	47,692	48,534	50,058	50,286	51,840	51,168	52,272	53,270
Preferred Stock	831	822	819	812	809	801	798	791	788	781	770
Total Common Equity	43,624	44,318	45,958	46,880	47,725	49,257	49,488	51,049	50,380	51,491	52,500
Common Stock	70,154	70,325	70,565	70,831	70,944	71,404	71,693	72,111	72,292	72,624	72,926
Retained Earnings	115,858	117,082	118,170	120,443	121,617	123,132	123,811	125,361	127,544	128,919	132,212
Treasury Stock	-129,012	-130,002	-129,736	-131,029	-131,887	-132,172	-133,379	-134,823	-137,112	-138,073	-139,845
Accumulated Other Comprehensive Income / (Loss)	-12,506	-12,266	-12,220	-12,583	-12,167	-12,370	-11,900	-10,893	-11,637	-11,307	-12,156
Other Equity Adjustments	-870	-821	-821	-782	-782	-737	-737	-707	-707	-672	-637
Noncontrolling Interest	270	281	288	321	294	275	272	300	275	273	281

This table displays calculated financial ratios and metrics derived from Procter & Gamble's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	6/30/2015	6/30/2016	6/30/2017	6/30/2018	6/30/2019	6/30/2020	6/30/2021	6/30/2022	6/30/2023	6/30/2024	6/30/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-4.91%	-7.70%	-0.37%	2.73%	1.27%	4.83%	7.28%	5.35%	2.27%	2.48%	0.29%
EBITDA Growth	-15.28%	15.19%	-2.81%	0.29%	-44.08%	108.64%	8.61%	1.84%	1.54%	2.76%	6.07%
EBIT Growth	-18.63%	19.82%	-1.56%	0.25%	-53.20%	153.92%	11.94%	1.72%	2.28%	2.19%	7.25%
NOPAT Growth	-24.23%	21.24%	5.00%	-6.58%	-63.74%	262.47%	12.75%	-0.07%	-0.55%	1.64%	10.06%
Net Income Growth	-39.38%	48.43%	45.33%	-36.01%	-59.78%	230.38%	9.53%	3.07%	-0.37%	1.60%	7.29%
EPS Growth	-39.15%	51.23%	51.49%	-34.35%	-61.04%	246.85%	10.89%	5.64%	1.55%	2.03%	8.14%
Operating Cash Flow Growth	4.66%	5.66%	-17.38%	16.58%	2.52%	14.18%	5.56%	-8.97%	0.75%	17.79%	-10.22%
Free Cash Flow Firm Growth	107.01%	-46.60%	-38.02%	12.11%	-13.08%	75.62%	-21.70%	1.26%	3.41%	19.73%	-14.26%
Invested Capital Growth	-19.57%	-5.41%	2.62%	0.12%	-6.82%	-2.92%	4.49%	4.07%	3.22%	0.15%	5.03%
Revenue Q/Q Growth	5.55%	-0.69%	-0.04%	0.64%	0.88%	0.86%	1.67%	0.71%	1.28%	-0.03%	0.43%
EBITDA Q/Q Growth	-7.42%	10.88%	0.53%	-3.54%	-44.28%	81.39%	-0.16%	0.43%	2.85%	-1.42%	2.66%
EBIT Q/Q Growth	-9.14%	13.36%	1.54%	-4.45%	-53.68%	114.05%	0.39%	0.43%	3.37%	-1.90%	3.23%
NOPAT Q/Q Growth	-15.33%	18.36%	2.00%	0.28%	-67.29%	165.85%	0.60%	0.87%	2.25%	-1.20%	2.11%
Net Income Q/Q Growth	-22.57%	15.46%	1.61%	-3.07%	-64.25%	157.93%	0.86%	1.02%	2.32%	-1.63%	3.09%
EPS Q/Q Growth	-22.54%	16.04%	2.38%	-2.39%	-66.03%	169.57%	1.29%	1.22%	2.79%	-1.63%	3.33%
Operating Cash Flow Q/Q Growth	-3.42%	0.99%	-3.42%	3.56%	-0.31%	3.91%	-3.59%	-2.38%	10.70%	2.13%	-4.14%
Free Cash Flow Firm Q/Q Growth	550.98%	-3.44%	-36.61%	69.44%	-11.93%	4.43%	-18.56%	14.45%	14.51%	5.61%	-9.21%
Invested Capital Q/Q Growth	-7.14%	-4.94%	2.26%	-3.20%	-11.34%	-1.72%	2.42%	0.34%	-1.33%	-2.58%	-0.43%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	47.62%	49.60%	49.83%	48.48%	48.63%	50.32%	51.25%	47.43%	47.86%	51.39%	51.16%
EBITDA Margin	20.67%	25.80%	25.16%	24.57%	13.57%	27.00%	27.34%	26.43%	26.24%	26.31%	27.83%
Operating Margin	15.62%	20.58%	21.16%	19.99%	8.11%	22.14%	23.63%	22.21%	22.11%	22.07%	24.26%
EBIT Margin	16.24%	21.08%	20.83%	20.33%	9.39%	22.75%	23.74%	22.93%	22.93%	22.86%	24.45%
Profit (Net Income) Margin	10.10%	16.24%	23.69%	14.75%	5.86%	18.47%	18.85%	18.45%	17.97%	17.82%	19.06%
Tax Burden Percent	64.87%	79.32%	116.25%	74.00%	65.35%	82.75%	81.48%	82.21%	80.30%	79.81%	79.66%
Interest Burden Percent	95.85%	97.12%	97.83%	98.09%	95.45%	98.08%	97.47%	97.89%	97.61%	97.65%	97.87%
Effective Tax Rate	24.75%	25.00%	23.10%	26.00%	34.65%	17.25%	18.52%	17.79%	19.70%	20.19%	20.34%
Return on Invested Capital (ROIC)	9.96%	13.92%	14.84%	13.68%	5.13%	19.57%	21.91%	21.00%	20.15%	20.14%	21.61%
ROIC Less NNEP Spread (ROIC-NNEP)	3.06%	18.32%	48.28%	13.53%	7.07%	20.13%	20.41%	21.65%	20.84%	20.84%	20.67%
Return on Net Nonoperating Assets (RNNOA)	0.78%	3.60%	12.25%	4.47%	2.76%	8.17%	8.78%	10.64%	11.24%	10.53%	9.63%
Return on Equity (ROE)	10.74%	17.52%	27.09%	18.15%	7.90%	27.74%	30.69%	31.64%	31.38%	30.68%	31.24%
Cash Return on Invested Capital (CROIC)	31.65%	19.48%	12.26%	13.56%	12.20%	22.54%	17.52%	17.01%	16.97%	19.99%	16.71%
Operating Return on Assets (OROA)	8.39%	10.73%	10.95%	11.38%	5.45%	13.69%	15.06%	15.54%	15.80%	15.80%	16.64%
Return on Assets (ROA)	5.22%	8.26%	12.45%	8.26%	3.40%	11.11%	11.96%	12.51%	12.38%	12.31%	12.98%
Return on Common Equity (ROCE)	10.45%	17.03%	26.31%	17.62%	7.67%	26.99%	29.90%	30.88%	30.64%	29.99%	30.60%
Return on Equity Simple (ROE_SIMPLE)	11.45%	18.49%	27.93%	18.86%	8.40%	28.22%	30.99%	31.75%	31.51%	29.78%	0.00%
Net Operating Profit after Tax (NOPAT)	8,315	10,081	10,585	9,888	3,586	12,997	14,654	14,643	14,562	14,802	16,291
NOPAT Margin	11.75%	15.44%	16.27%	14.80%	5.30%	18.32%	19.25%	18.26%	17.76%	17.61%	19.33%
Net Nonoperating Expense Percent (NNEP)	6.91%	-4.40%	-33.44%	0.15%	-1.94%	-0.55%	1.50%	-0.65%	-0.69%	-0.70%	0.94%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-	-	-	18.77%
Cost of Revenue to Revenue	52.38%	50.40%	50.17%	51.52%	51.37%	49.68%	48.75%	52.57%	52.14%	48.61%	48.84%
SG&A Expenses to Revenue	29.14%	29.02%	28.67%	28.48%	28.20%	28.18%	27.62%	25.21%	25.74%	27.73%	26.90%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	32.01%	29.02%	28.67%	28.48%	40.53%	28.18%	27.62%	25.21%	25.74%	29.33%	26.90%
Earnings before Interest and Taxes (EBIT)	11,489	13,766	13,551	13,585	6,358	16,144	18,072	18,383	18,802	19,213	20,605
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	14,623	16,844	16,371	16,419	9,182	19,157	20,807	21,190	21,516	22,109	23,452
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.70	3.23	3.43	3.29	5.28	5.91	6.78	7.12	7.54	7.82	7.24
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	2.34	2.79	2.85	2.53	3.61	3.80	4.05	4.06	4.23	4.60	4.40
Price to Earnings (P/E)	23.55	17.32	12.11	17.32	62.73	20.71	21.57	22.10	23.66	26.00	23.23
Dividend Yield	4.25%	4.86%	3.72%	4.15%	2.97%	2.78%	2.57%	2.59%	2.50%	2.34%	2.58%
Earnings Yield	4.25%	5.77%	8.25%	5.77%	1.59%	4.83%	4.64%	4.53%	4.23%	3.85%	4.31%
Enterprise Value to Invested Capital (EV/IC)	2.50	2.85	2.82	2.62	3.94	4.43	4.85	4.94	5.09	5.59	5.14
Enterprise Value to Revenue (EV/Rev)	2.63	3.08	3.13	2.84	3.92	4.08	4.35	4.38	4.56	4.89	4.71
Enterprise Value to EBITDA (EV/EBITDA)	12.73	11.93	12.44	11.56	28.92	15.11	15.92	16.57	17.39	18.59	16.93
Enterprise Value to EBIT (EV/EBIT)	16.20	14.60	15.03	13.97	41.77	17.94	18.33	19.10	19.90	21.39	19.27
Enterprise Value to NOPAT (EV/NOPAT)	22.39	19.93	19.25	19.20	74.06	22.28	22.61	23.98	25.69	27.76	24.37
Enterprise Value to Operating Cash Flow (EV/OCF)	12.74	13.02	15.97	12.77	17.42	16.64	18.03	21.00	22.20	20.71	22.28
Enterprise Value to Free Cash Flow (EV/FCFF)	7.05	14.24	23.30	19.37	31.17	19.35	28.27	29.60	30.49	27.98	31.52
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.48	0.53	0.57	0.59	0.63	0.74	0.69	0.67	0.74	0.64	0.66
Long-Term Debt to Equity	0.29	0.33	0.32	0.39	0.43	0.50	0.50	0.49	0.52	0.50	0.48
Financial Leverage	0.25	0.20	0.25	0.33	0.39	0.41	0.43	0.49	0.54	0.51	0.47
Leverage Ratio	2.06	2.12	2.18	2.20	2.32	2.50	2.57	2.53	2.53	2.49	2.41
Compound Leverage Factor	1.97	2.06	2.13	2.16	2.22	2.45	2.50	2.48	2.47	2.43	2.36
Debt to Total Capital	32.49%	34.54%	36.16%	37.17%	38.74%	42.55%	40.68%	40.20%	42.37%	39.10%	39.76%
Short-Term Debt to Total Capital	12.87%	13.16%	15.51%	12.38%	12.48%	13.71%	11.30%	11.03%	12.52%	8.66%	10.96%
Long-Term Debt to Total Capital	19.62%	21.39%	20.65%	24.79%	26.26%	28.85%	29.37%	29.16%	29.85%	30.44%	28.80%
Preferred Equity to Total Capital	1.15%	1.17%	1.15%	1.15%	1.19%	0.98%	1.02%	1.08%	1.00%	0.96%	0.90%
Noncontrolling Interests to Total Capital	0.68%	0.72%	0.68%	0.70%	0.50%	0.44%	0.35%	0.34%	0.35%	0.33%	0.31%
Common Equity to Total Capital	65.68%	63.56%	62.01%	60.98%	59.57%	55.91%	57.87%	58.39%	56.27%	59.61%	59.03%
Debt to EBITDA	2.08	1.82	1.93	1.91	3.28	1.81	1.54	1.49	1.61	1.47	1.47
Net Debt to EBITDA	1.28	1.02	1.01	1.18	2.16	0.97	1.04	1.15	1.23	1.04	1.06
Long-Term Debt to EBITDA	1.25	1.12	1.10	1.27	2.22	1.23	1.11	1.08	1.13	1.14	1.07
Debt to NOPAT	3.65	3.04	2.98	3.16	8.39	2.67	2.18	2.15	2.38	2.19	2.12
Net Debt to NOPAT	2.25	1.71	1.55	1.97	5.52	1.43	1.48	1.66	1.81	1.55	1.53
Long-Term Debt to NOPAT	2.20	1.88	1.70	2.11	5.69	1.81	1.58	1.56	1.67	1.71	1.53
Altman Z-Score	3.25	3.45	3.72	3.61	4.02	4.34	4.83	5.21	5.25	5.77	5.62
Noncontrolling Interest Sharing Ratio	2.69%	2.80%	2.88%	2.91%	2.86%	2.72%	2.57%	2.41%	2.36%	2.23%	2.06%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.00	1.10	0.88	0.83	0.75	0.85	0.70	0.65	0.63	0.73	0.70
Quick Ratio	0.54	0.58	0.65	0.59	0.51	0.13	0.45	0.16	0.38	0.46	0.44
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	26,417	14,106	8,743	9,802	8,521	14,964	11,717	11,864	12,269	14,690	12,595
Operating Cash Flow to CapEx	0.00%	535.57%	453.36%	431.18%	516.15%	571.90%	669.25%	549.02%	558.62%	666.87%	486.01%
Free Cash Flow to Firm to Interest Expense	42.20	24.36	18.80	19.37	16.74	32.18	23.34	27.03	16.23	15.88	13.89
Operating Cash Flow to Interest Expense	23.34	26.66	27.43	29.38	29.95	37.43	36.60	38.09	22.29	21.46	19.64
Operating Cash Flow Less CapEx to Interest Expense	24.55	21.68	21.38	22.57	24.14	30.88	31.13	31.15	18.30	18.24	15.60
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.52	0.51	0.53	0.56	0.58	0.60	0.63	0.68	0.69	0.69	0.68
Accounts Receivable Turnover	12.92	14.61	14.51	14.40	14.05	15.54	17.10	16.25	15.45	14.50	13.70
Inventory Turnover	6.31	6.79	6.99	7.36	7.13	6.70	6.46	6.53	6.11	5.80	5.65
Fixed Asset Turnover	3.37	3.35	3.31	3.30	3.23	3.38	3.59	3.74	3.81	3.81	3.66
Accounts Payable Turnover	4.46	3.77	3.44	3.45	3.22	3.02	2.88	2.95	2.90	2.73	2.69
Days Sales Outstanding (DSO)	28.26	24.99	25.15	25.34	25.98	23.48	21.35	22.46	23.62	25.17	26.64
Days Inventory Outstanding (DIO)	57.81	53.76	52.23	49.62	51.20	54.44	56.46	55.88	59.74	62.95	64.58
Days Payable Outstanding (DPO)	81.75	96.84	106.00	105.88	113.40	120.79	126.84	123.82	125.82	133.86	135.62
Cash Conversion Cycle (CCC)	4.32	-18.09	-28.62	-30.92	-36.21	-42.87	-49.03	-45.49	-42.46	-45.75	-44.41
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	74,416	70,391	72,233	72,319	67,384	65,417	68,354	71,133	73,426	73,538	77,234
Invested Capital Turnover	0.85	0.90	0.91	0.92	0.97	1.07	1.14	1.15	1.13	1.14	1.12
Increase / (Decrease) in Invested Capital	-18,102	-4,025	1,842	86	-4,935	-1,967	2,937	2,779	2,293	112	3,696
Enterprise Value (EV)	186,145	200,934	203,721	189,826	265,560	289,544	331,297	351,159	374,097	410,956	396,997
Market Capitalization	165,695	182,004	185,666	168,833	244,442	269,848	308,521	325,772	346,629	386,908	370,996
Book Value per Share	$22.61	$21.15	$21.18	$20.41	$18.44	$18.43	$18.59	$19.07	$19.50	$20.97	$21.85
Tangible Book Value per Share	($3.06)	($4.72)	($5.75)	($7.06)	($7.26)	($7.30)	($7.78)	($7.35)	($7.84)	($5.45)	($5.26)
Total Capital	93,395	88,581	87,370	84,169	77,671	81,598	78,642	78,347	81,672	83,019	86,792
Total Debt	30,345	30,598	31,592	31,286	30,092	34,720	31,988	31,493	34,607	32,460	34,508
Total Long-Term Debt	18,327	18,945	18,038	20,863	20,395	23,537	23,099	22,848	24,378	25,269	24,995
Net Debt	18,742	17,250	16,455	19,436	19,805	18,539	21,700	24,279	26,361	22,978	24,952
Capital Expenditures (CapEx)	-762	2,882	2,813	3,448	2,953	3,043	2,745	3,046	3,016	2,976	3,666
Debt-free, Cash-free Net Working Capital (DFCFNWC)	271	1,317	-5,299	-6,344	-8,128	-9,987	-11,440	-9,997	-11,125	-11,209	-10,709
Debt-free Net Working Capital (DFNWC)	11,874	14,665	9,838	5,506	2,159	6,194	-1,152	-2,783	-2,879	-1,727	-1,153
Net Working Capital (NWC)	-144	3,012	-3,716	-4,917	-7,538	-4,989	-10,041	-11,428	-13,108	-8,918	-10,666
Net Nonoperating Expense (NNE)	1,171	-523	-4,826	27	-380	-106	302	-150	-176	-172	226
Net Nonoperating Obligations (NNO)	11,366	12,408	16,455	19,436	19,805	18,539	21,700	24,279	26,361	22,979	24,950
Total Depreciation and Amortization (D&A)	3,134	3,078	2,820	2,834	2,824	3,013	2,735	2,807	2,714	2,896	2,847
Debt-free, Cash-free Net Working Capital to Revenue	0.38%	2.02%	-8.15%	-9.49%	-12.01%	-14.08%	-15.03%	-12.47%	-13.57%	-13.34%	-12.71%
Debt-free Net Working Capital to Revenue	16.78%	22.46%	15.12%	8.24%	3.19%	8.73%	-1.51%	-3.47%	-3.51%	-2.06%	-1.37%
Net Working Capital to Revenue	-0.20%	4.61%	-5.71%	-7.36%	-11.14%	-7.03%	-13.19%	-14.25%	-15.98%	-10.61%	-12.65%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$2.50	$3.80	$5.80	$0.00	$1.45	$5.13	$5.69	$6.00	$6.07	$6.18	$6.67
Adjusted Weighted Average Basic Shares Outstanding	2.71B	2.67B	2.55B	0.00	2.50B	4.97B	4.85B	4.78B	4.71B	2.35B	2.34B
Adjusted Diluted Earnings per Share	$2.44	$3.69	$5.59	$0.00	$1.43	$4.96	$5.50	$5.81	$5.90	$6.02	$6.51
Adjusted Weighted Average Diluted Shares Outstanding	2.71B	2.67B	2.55B	0.00	2.50B	4.97B	4.85B	4.78B	4.71B	2.35B	2.34B
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	2.71B	2.67B	2.55B	0.00	2.50B	4.97B	4.85B	4.78B	4.71B	2.35B	2.34B
Normalized Net Operating Profit after Tax (NOPAT)	8,315	10,081	10,585	9,888	9,039	12,997	14,654	14,643	14,562	15,872	16,291
Normalized NOPAT Margin	11.75%	15.44%	16.27%	14.80%	13.35%	18.32%	19.25%	18.26%	17.76%	18.89%	19.33%
Pre Tax Income Margin	15.56%	20.47%	20.38%	19.94%	8.97%	22.32%	23.14%	22.44%	22.38%	22.32%	23.93%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	18.35	23.78	29.14	26.85	12.49	34.72	36.00	41.87	24.87	20.77	22.72
NOPAT to Interest Expense	13.28	17.41	22.76	19.54	7.04	27.95	29.19	33.36	19.26	16.00	17.96
EBIT Less CapEx to Interest Expense	19.57	18.80	23.09	20.03	6.69	28.17	30.53	34.94	20.88	17.55	18.68
NOPAT Less CapEx to Interest Expense	14.50	12.43	16.71	12.73	1.24	21.41	23.72	26.42	15.27	12.78	13.92
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	102.00%	70.12%	46.95%	74.13%	189.06%	59.44%	57.57%	59.28%	61.06%	62.19%	61.45%
Augmented Payout Ratio	166.45%	107.88%	80.72%	145.16%	315.20%	115.96%	134.28%	126.90%	110.95%	95.62%	101.91%

This table displays calculated financial ratios and metrics derived from Procter & Gamble's official financial filings.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	3.54%	5.32%	6.11%	3.22%	0.63%	-0.10%	-0.61%	2.06%	-2.07%	1.74%	2.99%
EBITDA Growth	5.31%	13.37%	14.98%	-4.68%	6.11%	-6.28%	-9.54%	25.14%	0.48%	12.79%	15.31%
EBIT Growth	6.14%	16.37%	16.17%	-6.68%	6.62%	-8.56%	-11.12%	29.39%	1.02%	16.19%	16.80%
NOPAT Growth	1.92%	10.64%	15.61%	-12.10%	8.23%	-5.36%	-0.68%	32.84%	1.03%	10.66%	3.16%
Net Income Growth	1.69%	10.92%	14.96%	-11.77%	10.43%	-7.31%	-12.49%	33.38%	0.32%	15.33%	19.91%
EPS Growth	3.01%	13.22%	16.56%	-11.95%	10.95%	-7.30%	-12.02%	34.29%	1.32%	16.54%	21.12%
Operating Cash Flow Growth	19.01%	43.85%	20.49%	42.70%	5.82%	7.73%	-12.28%	-5.39%	-9.37%	-13.36%	25.71%
Free Cash Flow Firm Growth	83.60%	342.63%	-46.91%	824.26%	2,026.29%	192.14%	153.21%	115.61%	-37.36%	-106.67%	-2.77%
Invested Capital Growth	4.98%	3.22%	5.00%	2.61%	1.44%	0.15%	2.67%	1.67%	2.76%	5.03%	2.88%
Revenue Q/Q Growth	-3.39%	2.42%	6.41%	-1.97%	-5.81%	1.67%	5.87%	0.67%	-9.62%	5.63%	7.17%
EBITDA Q/Q Growth	-8.47%	-1.09%	30.38%	-19.24%	1.89%	-12.65%	25.84%	11.72%	-18.18%	-1.94%	28.64%
EBIT Q/Q Growth	-10.38%	-1.58%	35.39%	-21.85%	2.39%	-15.59%	31.60%	13.77%	-20.07%	-2.92%	32.30%
NOPAT Q/Q Growth	-13.43%	-1.68%	35.78%	-23.95%	6.60%	-14.03%	42.50%	1.72%	-18.93%	-5.83%	32.84%
Net Income Q/Q Growth	-13.51%	-0.93%	34.32%	-23.33%	8.25%	-16.85%	26.81%	16.85%	-18.59%	-4.40%	31.85%
EPS Q/Q Growth	-13.84%	0.00%	33.58%	-23.50%	8.57%	-16.45%	26.77%	16.77%	-18.09%	-3.90%	31.76%
Operating Cash Flow Q/Q Growth	8.09%	38.26%	-8.18%	4.00%	-19.84%	40.75%	-25.23%	12.16%	-23.21%	34.55%	8.49%
Free Cash Flow Firm Q/Q Growth	-180.77%	872.27%	-4.47%	55.10%	68.35%	17.12%	-17.20%	32.07%	-51.09%	-112.48%	1,306.55%
Invested Capital Q/Q Growth	2.29%	-1.33%	1.00%	0.66%	1.12%	-2.58%	3.53%	-0.31%	2.20%	-0.43%	1.41%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	48.16%	48.36%	51.99%	52.69%	51.20%	49.60%	52.06%	52.39%	50.98%	49.11%	51.37%
EBITDA Margin	25.51%	24.63%	30.18%	24.86%	26.90%	23.11%	27.47%	30.49%	27.60%	25.62%	30.76%
Operating Margin	21.17%	20.25%	26.37%	20.68%	22.08%	18.92%	26.67%	26.24%	23.05%	20.85%	26.16%
EBIT Margin	22.06%	21.20%	26.97%	21.50%	23.37%	19.40%	24.12%	27.26%	24.11%	22.16%	27.36%
Profit (Net Income) Margin	17.06%	16.50%	20.83%	16.29%	18.72%	15.31%	18.34%	21.29%	19.18%	17.36%	21.36%
Tax Burden Percent	79.85%	80.13%	78.52%	77.69%	82.34%	81.22%	77.57%	79.71%	81.38%	80.20%	79.23%
Interest Burden Percent	96.86%	97.15%	98.36%	97.53%	97.29%	97.16%	98.04%	97.99%	97.76%	97.67%	98.53%
Effective Tax Rate	20.15%	19.87%	21.48%	22.31%	17.68%	18.75%	22.41%	20.31%	18.62%	19.80%	20.77%
Return on Invested Capital (ROIC)	18.84%	18.41%	23.82%	18.29%	20.39%	17.58%	23.10%	23.43%	20.57%	18.69%	22.79%
ROIC Less NNEP Spread (ROIC-NNEP)	18.96%	18.64%	23.92%	18.47%	20.79%	17.53%	21.07%	23.76%	20.90%	19.25%	23.37%
Return on Net Nonoperating Assets (RNNOA)	11.26%	10.05%	13.58%	10.63%	11.76%	8.86%	10.55%	11.91%	10.20%	8.97%	10.79%
Return on Equity (ROE)	30.09%	28.46%	37.40%	28.93%	32.15%	26.44%	33.65%	35.34%	30.76%	27.67%	33.58%
Cash Return on Invested Capital (CROIC)	14.75%	16.97%	16.08%	17.37%	18.56%	19.99%	17.04%	19.49%	18.13%	16.71%	18.42%
Operating Return on Assets (OROA)	14.88%	14.61%	18.81%	15.14%	16.41%	13.41%	16.25%	18.90%	16.68%	15.09%	18.29%
Return on Assets (ROA)	11.51%	11.37%	14.53%	11.47%	13.15%	10.58%	12.36%	14.76%	13.27%	11.82%	14.28%
Return on Common Equity (ROCE)	29.36%	27.79%	36.50%	28.24%	31.42%	25.85%	32.90%	34.58%	30.13%	27.10%	32.90%
Return on Equity Simple (ROE_SIMPLE)	31.91%	0.00%	32.15%	30.63%	30.41%	0.00%	27.79%	30.43%	29.81%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	3,392	3,335	4,529	3,444	3,671	3,156	4,498	4,575	3,709	3,493	4,640
NOPAT Margin	16.90%	16.23%	20.71%	16.06%	18.18%	15.37%	20.69%	20.91%	18.76%	16.72%	20.73%
Net Nonoperating Expense Percent (NNEP)	-0.12%	-0.22%	-0.10%	-0.18%	-0.41%	0.05%	2.04%	-0.33%	-0.33%	-0.56%	-0.58%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	4.17%	-	-	-	5.31%	4.28%	4.02%	5.18%
Cost of Revenue to Revenue	51.84%	51.64%	48.01%	47.31%	48.80%	50.40%	47.94%	47.61%	49.02%	50.89%	48.63%
SG&A Expenses to Revenue	26.99%	28.11%	25.62%	25.75%	29.12%	30.68%	25.39%	26.15%	27.93%	28.26%	25.21%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	26.99%	28.11%	25.62%	32.01%	29.12%	30.68%	25.39%	26.15%	27.93%	28.26%	25.21%
Earnings before Interest and Taxes (EBIT)	4,427	4,357	5,899	4,610	4,720	3,984	5,243	5,965	4,768	4,629	6,124
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	5,119	5,063	6,601	5,331	5,432	4,745	5,971	6,671	5,458	5,352	6,885
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	7.67	7.54	7.11	7.06	7.70	7.82	7.94	7.84	7.71	7.24	6.81
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	4.20	4.23	4.00	4.02	4.51	4.60	4.83	4.68	4.73	4.40	4.21
Price to Earnings (P/E)	23.73	23.66	21.88	22.82	25.08	26.00	28.31	25.51	25.63	23.23	21.32
Dividend Yield	2.54%	2.50%	2.62%	2.61%	2.33%	2.34%	2.26%	2.36%	2.38%	2.58%	2.70%
Earnings Yield	4.21%	4.23%	4.57%	4.38%	3.99%	3.85%	3.53%	3.92%	3.90%	4.31%	4.69%
Enterprise Value to Invested Capital (EV/IC)	4.97	5.09	4.86	4.87	5.37	5.59	5.65	5.54	5.46	5.14	4.89
Enterprise Value to Revenue (EV/Rev)	4.57	4.56	4.33	4.34	4.82	4.89	5.13	4.98	5.04	4.71	4.51
Enterprise Value to EBITDA (EV/EBITDA)	17.69	17.39	16.12	16.46	18.08	18.59	20.04	18.42	18.53	16.93	15.73
Enterprise Value to EBIT (EV/EBIT)	20.34	19.90	18.38	18.86	20.71	21.39	23.19	21.11	21.20	19.27	17.84
Enterprise Value to NOPAT (EV/NOPAT)	25.98	25.69	23.77	24.76	27.07	27.76	29.11	26.40	26.53	24.37	23.34
Enterprise Value to Operating Cash Flow (EV/OCF)	24.31	22.20	20.40	18.95	20.87	20.71	22.37	22.16	22.77	22.28	20.25
Enterprise Value to Free Cash Flow (EV/FCFF)	34.53	30.49	30.98	28.43	29.16	27.98	33.61	28.65	30.51	31.52	26.94
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.81	0.74	0.75	0.69	0.64	0.64	0.69	0.67	0.65	0.66	0.67
Long-Term Debt to Equity	0.50	0.52	0.50	0.47	0.48	0.50	0.49	0.49	0.46	0.48	0.45
Financial Leverage	0.59	0.54	0.57	0.58	0.57	0.51	0.50	0.50	0.49	0.47	0.46
Leverage Ratio	2.63	2.53	2.59	2.55	2.50	2.49	2.49	2.43	2.36	2.41	2.40
Compound Leverage Factor	2.55	2.46	2.54	2.49	2.43	2.42	2.44	2.38	2.31	2.35	2.37
Debt to Total Capital	44.62%	42.37%	42.77%	40.84%	38.85%	39.10%	40.95%	40.27%	39.38%	39.76%	40.16%
Short-Term Debt to Total Capital	16.73%	12.52%	14.08%	12.86%	9.39%	8.66%	11.79%	10.94%	11.41%	10.96%	13.00%
Long-Term Debt to Total Capital	27.89%	29.85%	28.69%	27.98%	29.46%	30.44%	29.16%	29.33%	27.98%	28.80%	27.17%
Preferred Equity to Total Capital	1.00%	1.00%	0.97%	0.98%	0.97%	0.96%	0.90%	0.91%	0.90%	0.90%	0.86%
Noncontrolling Interests to Total Capital	0.34%	0.35%	0.38%	0.36%	0.33%	0.33%	0.34%	0.32%	0.31%	0.31%	0.31%
Common Equity to Total Capital	54.04%	56.27%	55.88%	57.82%	59.84%	59.61%	57.82%	58.49%	59.40%	59.03%	58.66%
Debt to EBITDA	1.75	1.61	1.60	1.52	1.43	1.47	1.68	1.52	1.49	1.47	1.48
Net Debt to EBITDA	1.39	1.23	1.17	1.17	1.12	1.04	1.12	1.07	1.10	1.06	1.02
Long-Term Debt to EBITDA	1.09	1.13	1.08	1.04	1.08	1.14	1.20	1.11	1.06	1.07	1.00
Debt to NOPAT	2.57	2.38	2.36	2.29	2.13	2.19	2.45	2.18	2.14	2.12	2.19
Net Debt to NOPAT	2.04	1.81	1.72	1.76	1.68	1.55	1.62	1.54	1.57	1.53	1.51
Long-Term Debt to NOPAT	1.61	1.67	1.59	1.57	1.62	1.71	1.74	1.59	1.52	1.53	1.48
Altman Z-Score	4.75	4.86	4.78	4.92	5.46	5.36	5.37	5.55	5.57	5.20	5.07
Noncontrolling Interest Sharing Ratio	2.43%	2.36%	2.41%	2.36%	2.28%	2.23%	2.22%	2.16%	2.07%	2.06%	2.03%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.59	0.63	0.67	0.64	0.69	0.73	0.75	0.76	0.71	0.70	0.71
Quick Ratio	0.14	0.38	0.17	0.18	0.40	0.46	0.51	0.49	0.45	0.44	0.46
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-135	1,042	996	1,544	2,599	3,044	2,521	3,329	1,628	-203	2,451
Operating Cash Flow to CapEx	529.90%	766.28%	531.89%	628.08%	561.54%	1,119.46%	453.80%	522.75%	440.02%	523.09%	453.69%
Free Cash Flow to Firm to Interest Expense	-0.61	4.34	4.42	6.23	11.16	13.90	10.59	13.87	7.50	-0.96	12.44
Operating Cash Flow to Interest Expense	17.40	22.25	21.80	20.56	17.55	26.27	18.08	20.10	17.07	23.51	27.45
Operating Cash Flow Less CapEx to Interest Expense	14.12	19.35	17.70	17.29	14.42	23.93	14.09	16.26	13.19	19.02	21.40
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.67	0.69	0.70	0.70	0.70	0.69	0.67	0.69	0.69	0.68	0.67
Accounts Receivable Turnover	14.74	15.45	13.95	13.87	14.50	14.50	13.39	13.42	13.69	13.70	13.27
Inventory Turnover	5.89	6.11	5.77	5.67	5.65	5.80	5.66	5.79	5.65	5.65	5.50
Fixed Asset Turnover	3.78	3.81	3.94	3.88	3.86	3.81	3.80	3.82	3.75	3.66	3.64
Accounts Payable Turnover	3.07	2.90	2.90	2.94	2.99	2.73	2.74	2.86	2.90	2.69	2.69
Days Sales Outstanding (DSO)	24.76	23.62	26.16	26.31	25.17	25.17	27.25	27.19	26.67	26.64	27.51
Days Inventory Outstanding (DIO)	61.97	59.74	63.28	64.36	64.64	62.95	64.48	63.02	64.63	64.58	66.35
Days Payable Outstanding (DPO)	118.83	125.82	125.98	124.35	121.99	133.86	133.33	127.75	125.90	135.62	135.72
Cash Conversion Cycle (CCC)	-32.10	-42.46	-36.54	-33.67	-32.18	-45.75	-41.60	-37.54	-34.60	-44.41	-41.86
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	74,416	73,426	74,160	74,653	75,488	73,538	76,137	75,899	77,569	77,234	78,326
Invested Capital Turnover	1.11	1.13	1.15	1.14	1.12	1.14	1.12	1.12	1.10	1.12	1.10
Increase / (Decrease) in Invested Capital	3,527	2,293	3,533	1,900	1,072	112	1,977	1,246	2,081	3,696	2,189
Enterprise Value (EV)	369,990	374,097	360,665	363,917	405,560	410,956	430,428	420,343	423,214	396,997	383,233
Market Capitalization	339,892	346,629	333,385	336,992	379,330	386,908	405,340	394,823	397,135	370,996	357,407
Book Value per Share	$18.79	$19.50	$19.89	$20.25	$20.93	$20.97	$21.69	$21.39	$21.96	$21.85	$22.41
Tangible Book Value per Share	($8.58)	($7.84)	($7.21)	($6.57)	($5.74)	($5.45)	($5.09)	($4.82)	($4.61)	($5.26)	($4.68)
Total Capital	82,012	81,672	83,894	82,541	82,315	83,019	88,294	86,130	86,686	86,792	89,497
Total Debt	36,591	34,607	35,880	33,712	31,982	32,460	36,153	34,687	34,141	34,508	35,946
Total Long-Term Debt	22,874	24,378	24,069	23,096	24,253	25,269	25,744	25,263	24,252	24,995	24,315
Net Debt	28,995	26,361	26,147	25,822	25,154	22,978	23,997	24,457	25,025	24,952	24,775
Capital Expenditures (CapEx)	729	697	922	812	728	514	948	923	842	953	1,192
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-9,604	-11,125	-10,140	-10,113	-8,981	-11,209	-10,718	-8,961	-9,040	-10,709	-10,417
Debt-free Net Working Capital (DFNWC)	-2,008	-2,879	-407	-2,223	-2,153	-1,727	1,438	1,269	76	-1,153	754
Net Working Capital (NWC)	-15,725	-13,108	-12,218	-12,839	-9,882	-8,918	-8,971	-8,155	-9,813	-10,666	-10,877
Net Nonoperating Expense (NNE)	-32	-57	-27	-49	-110	12	511	-84	-84	-133	-141
Net Nonoperating Obligations (NNO)	28,995	26,361	26,146	25,824	25,155	22,979	23,996	24,456	25,024	24,950	24,775
Total Depreciation and Amortization (D&A)	692	706	702	721	712	761	728	706	690	723	761
Debt-free, Cash-free Net Working Capital to Revenue	-11.86%	-13.57%	-12.18%	-12.05%	-10.68%	-13.34%	-12.77%	-10.62%	-10.77%	-12.71%	-12.27%
Debt-free Net Working Capital to Revenue	-2.48%	-3.51%	-0.49%	-2.65%	-2.56%	-2.06%	1.71%	1.50%	0.09%	-1.37%	0.89%
Net Working Capital to Revenue	-19.42%	-15.98%	-14.67%	-15.30%	-11.76%	-10.61%	-10.69%	-9.67%	-11.69%	-12.65%	-12.81%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.41	$1.41	$1.89	$1.44	$1.56	$1.29	$1.65	$1.94	$1.58	$1.50	$2.00
Adjusted Weighted Average Basic Shares Outstanding	2.36B	4.71B	2.36B	2.35B	2.36B	2.35B	2.36B	2.34B	2.34B	2.34B	2.34B
Adjusted Diluted Earnings per Share	$1.37	$1.37	$1.83	$1.40	$1.52	$1.27	$1.61	$1.88	$1.54	$1.48	$1.95
Adjusted Weighted Average Diluted Shares Outstanding	2.47B	4.71B	2.36B	2.35B	2.36B	2.35B	2.36B	2.34B	2.34B	2.34B	2.34B
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	2.36B	4.71B	2.36B	2.35B	2.36B	2.35B	2.36B	2.34B	2.34B	2.34B	2.34B
Normalized Net Operating Profit after Tax (NOPAT)	3,392	3,335	4,529	4,486	3,671	3,156	4,498	4,575	3,709	3,493	4,640
Normalized NOPAT Margin	16.90%	16.23%	20.71%	20.92%	18.18%	15.37%	20.69%	20.91%	18.76%	16.72%	20.73%
Pre Tax Income Margin	21.37%	20.60%	26.53%	20.97%	22.74%	18.85%	23.65%	26.71%	23.57%	21.64%	26.95%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	19.94	18.15	26.22	18.59	20.26	18.19	22.03	24.85	21.97	21.83	31.09
NOPAT to Interest Expense	15.28	13.90	20.13	13.89	15.76	14.41	18.90	19.06	17.09	16.48	23.55
EBIT Less CapEx to Interest Expense	16.66	15.25	22.12	15.31	17.13	15.84	18.05	21.01	18.09	17.34	25.04
NOPAT Less CapEx to Interest Expense	12.00	10.99	16.03	10.61	12.63	12.07	14.91	15.22	13.21	11.98	17.50
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	62.29%	61.06%	58.93%	61.16%	60.12%	62.19%	65.72%	61.78%	62.68%	61.45%	59.17%
Augmented Payout Ratio	122.01%	110.95%	90.58%	87.08%	83.05%	95.62%	103.52%	106.43%	109.63%	101.91%	93.64%

Financials Breakdown Chart

Key Financial Trends

Procter & Gamble (NYSE: PG) has demonstrated steady financial performance over the past four years, with generally positive trends in revenue, profitability, and cash flow, although there are some considerations for investors to keep in mind.

Key Positive Financial Trends:

Total revenue has consistently grown year-over-year, reaching approximately $20.9 billion in Q4 2025, up from $18.1 billion in Q3 2021, indicating robust demand for P&G's products.
Net income has shown a gradual upward trend, with Q4 2025 net income of roughly $3.6 billion compared to about $3.2 billion in Q3 2021, reflecting improved profitability.
Gross profit margins have remained strong, supported by disciplined cost management, as operating costs have not outpaced revenue growth significantly.
Operating income in Q4 2025 stood at $4.35 billion, maintaining a healthy margin and reflecting effective operational efficiency.
P&G maintains strong cash flow from operating activities, with $4.99 billion generated in Q4 2025, supporting investments and shareholder returns.
The company continues to invest prudently in property, plant, and equipment (around $996 million in Q4 2025), balancing growth with capital expenditures.
P&G has sustained dividend payments and repurchases of common equity, indicating confidence in its cash generation and commitment to returning capital to shareholders.
Share buybacks have been consistent, with $700 million spent on repurchasing stock in Q4 2025, which can support earnings per share growth.
Interest expense remains manageable relative to earnings, mitigating risks related to leverage.

Neutral Financial Aspects:

Total liabilities have increased modestly over the period, but the company maintains a balanced capital structure with a manageable long-term debt load around $24 billion as of Q3 2025.
Cash and equivalents fluctuate each quarter, ending Q4 2025 at about $9.1 billion, giving P&G flexibility in liquidity without significant cash pile accumulation.
Weighted average shares outstanding have slightly decreased over the years due to repurchases, impacting EPS interpretation.
Depreciation and non-cash adjustments vary but are in line with capital expenditures and asset base size.
Other income/expenditure shows occasional volatility that marginally impacts pre-tax income but remains a small portion of total income.

Potential Challenges and Negative Considerations:

Selling, General & Administrative (SG&A) expenses have risen somewhat in absolute terms, which could pressure margins if revenue growth slows or cost inflation accelerates.
Impairment charges appeared in some quarters (notably in Q2 2024), negatively impacting operating expenses and net income.
Net cash used in financing activities has been significant due to debt repayments and share repurchases, potentially limiting financial flexibility.
Interest expense, while controlled, has increased slightly from earlier periods, so rising rates could impact future financial costs.
Some quarters recorded negative net changes in cash and equivalents, reflecting timing differences in cash flows and potential liquidity considerations.

Summary: Over the last four years, Procter & Gamble has exhibited resilient revenue growth, solid profitability, and strong operational cash flow, supporting sustained shareholder returns through dividends and buybacks. While cost pressures and financial leverage warrant attention, the company’s stable financial position and strategic investment suggest it is well-positioned for continued value creation.

10/24/25 10:50 PM ETAI Generated. May Contain Errors.

Frequently Asked Questions About Procter & Gamble's Financials

When does Procter & Gamble's fiscal year end?

According to the most recent income statement we have on file, Procter & Gamble's financial year ends in June. Their financial year 2025 ended on June 30, 2025.

How has Procter & Gamble's net income changed over the last 10 years?

Procter & Gamble's net income appears to be on an upward trend, with a most recent value of $16.07 billion in 2025, rising from $7.14 billion in 2015. The previous period was $14.97 billion in 2024. View Procter & Gamble's forecast to see where analysts expect Procter & Gamble to go next.

What is Procter & Gamble's operating income?

Procter & Gamble's total operating income in 2025 was $20.45 billion, based on the following breakdown:

Total Gross Profit: $43.12 billion
Total Operating Expenses: $22.67 billion

How has Procter & Gamble's revenue changed over the last 10 years?

Over the last 10 years, Procter & Gamble's total revenue changed from $70.75 billion in 2015 to $84.28 billion in 2025, a change of 19.1%.

How much debt does Procter & Gamble have?

Procter & Gamble's total liabilities were at $72.95 billion at the end of 2025, a 1.6% increase from 2024, and a 9.8% increase since 2015.

How much cash does Procter & Gamble have?

In the past 10 years, Procter & Gamble's cash and equivalents has ranged from $0.00 in 2020 to $10.29 billion in 2021, and is currently $9.56 billion as of their latest financial filing in 2025.

How has Procter & Gamble's book value per share changed over the last 10 years?

Over the last 10 years, Procter & Gamble's book value per share changed from 22.61 in 2015 to 21.85 in 2025, a change of -3.4%.

Related Companies

This page (NYSE:PG) was last updated on 10/25/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Procter & Gamble (PG) Financials

Financials Breakdown Chart

Key Financial Trends

Frequently Asked Questions About Procter & Gamble's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Procter & Gamble (PG) Financials

Annual Income Statements for Procter & Gamble

Quarterly Income Statements for Procter & Gamble

Annual Cash Flow Statements for Procter & Gamble

Quarterly Cash Flow Statements for Procter & Gamble

Annual Balance Sheets for Procter & Gamble

Quarterly Balance Sheets for Procter & Gamble

Annual Metrics And Ratios for Procter & Gamble

Quarterly Metrics And Ratios for Procter & Gamble

Financials Breakdown Chart

Key Financial Trends

Frequently Asked Questions About Procter & Gamble's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools